These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet. Weghuber D, Widhalm K. Br J Nutr; 2008 Feb; 99(2):281-6. PubMed ID: 17697400 [Abstract] [Full Text] [Related]
27. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Descamps OS, Tenoutasse S, Stephenne X, Gies I, Beauloye V, Lebrethon MC, De Beaufort C, De Waele K, Scheen A, Rietzschel E, Mangano A, Panier JP, Ducobu J, Langlois M, Balligand JL, Legat P, Blaton V, Muls E, Van Gaal L, Sokal E, Rooman R, Carpentier Y, De Backer G, Heller FR. Atherosclerosis; 2011 Oct; 218(2):272-80. PubMed ID: 21762914 [Abstract] [Full Text] [Related]
31. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche JC, Descamps OS, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjærg-Hansen A, Wiklund O, European Atherosclerosis Society Consensus Panel. Eur Heart J; 2015 Sep 21; 36(36):2425-37. PubMed ID: 26009596 [Abstract] [Full Text] [Related]
32. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group. Am Heart J; 2004 Sep 21; 148(3):447-55. PubMed ID: 15389231 [Abstract] [Full Text] [Related]
33. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. Rodenburg J, Vissers MN, Wiegman A, Miller ER, Ridker PM, Witztum JL, Kastelein JJ, Tsimikas S. J Am Coll Cardiol; 2006 May 02; 47(9):1803-10. PubMed ID: 16682304 [Abstract] [Full Text] [Related]
34. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children. Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, Sijbrands EJ. Circulation; 2003 Mar 25; 107(11):1473-8. PubMed ID: 12654602 [Abstract] [Full Text] [Related]
35. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program. Arterioscler Thromb Vasc Biol; 2004 Aug 25; 24(8):e149-61. PubMed ID: 15297292 [Abstract] [Full Text] [Related]
36. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program. J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046 [Abstract] [Full Text] [Related]
37. [Three-year-old boy--a homozygote for familiar hypercholesterolemia]. Dumić M, Uroic AS, Francetić I, Puretić Z, Matisić D, Kes P, Mikecin M, Reiner Z. Lijec Vjesn; 2007 May 04; 129(5):130-3. PubMed ID: 17695192 [Abstract] [Full Text] [Related]
40. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]. Ose L, Tonstad S, Vesterhus P, Wefring KW. Tidsskr Nor Laegeforen; 1995 Nov 20; 115(28):3499-503. PubMed ID: 7491603 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]